SARS-CoV-2 RNAemia and Disease Severity in COVID-19 Patients

Abstract

Our study demonstrated that SARS-CoV-2 RNAemia is a predictive risk factor for clinical severity in COVID-19 patients. Hence, we showed that blood RNAemia might be a critical marker for disease severity and mortality.